Patents by Inventor David Knight

David Knight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for enforcing change policy based on project state
    Patent number: 8645906
    Abstract: A set of tools and other mechanisms automatically enforce software development change policies by providing a way to map physical source control system codelines to projects and by providing a way to maintain current project and codeline state information. The set of tools and other mechanisms also provide ways to define change management rules and policies, as well as, ways to evaluate and allow or deny each proposed change against the defined change policy.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: February 4, 2014
    Inventors: Sandeep Jain, David Knight
  • Methods and apparatuses for managing resources within a virtual room
    Patent number: 8645463
    Abstract: In one embodiment, the methods and apparatuses display a list configured to represent a plurality of virtual rooms; identify a selected participant device associated with a selected virtual room from the plurality of virtual rooms wherein the selected participant device is a member of the selected virtual room; selectively display content associated with the selected virtual room to the selected participant device; and notify the selected participant device of a change to the content associated with the selected virtual room.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: February 4, 2014
    Assignee: Cisco Technology, Inc.
    Inventors: David Knight, Christopher Daniels, Steffen Matt
  • Quinoline derivatives as PI3 kinase inhibitors
    Patent number: 8633187
    Abstract: Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: January 21, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Steven David Knight, Stanley J. Schmidt
  • Compounds, compositions and methods
    Patent number: 8633236
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: January 21, 2014
    Assignee: Cytokinetics, Inc.
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, Jr., Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • MALICIOUS MESSAGE DETECTION AND PROCESSING
    Publication number: 20130333026
    Abstract: Malicious message detection and processing systems and methods are provided herein. According to some embodiments, the messages are emails and the method for processing emails may be facilitated by way of an intermediary node which may be cloud-based. The intermediary node may be communicatively couplable with an email client and an email server. The intermediary node may execute a method that includes analyzing a link included in an email to determine if the link is associated with a potentially malicious resource, and replacing the link with an alternate link to a trusted resource if the link is associated with a potentially malicious resource.
    Type: Application
    Filed: June 7, 2012
    Publication date: December 12, 2013
    Inventors: Angelo Starink, David Knight
  • SOLAR PANEL AND GLAZING PANEL
    Publication number: 20130312736
    Abstract: This invention relates to a solar panel, and in particular to a solar panel designed to absorb heat from solar radiation. The invention provides a solar panel adapted to fit between two sheets of glass in a glazing panel, the solar panel being adapted to absorb heat from a proportion of the incident light, and to permit another proportion of the incident light to be transmitted through the solar panel and the glazing panel. The invention also provides a glazing panel fitted with a solar panel.
    Type: Application
    Filed: February 3, 2012
    Publication date: November 28, 2013
    Inventor: Michael David Knight
  • Token-based control of permitted sub-sessions for online collaborative computing sessions
    Patent number: 8578465
    Abstract: In one embodiment, a client device may send one or more sub-session requests to one or more corresponding session controllers through a computer network to obtain one or more corresponding sub-session tokens that indicate in which sub-sessions of an online collaborative computing session the client device is permitted to participate. The client device may then receive particular sub-session tokens (e.g., based on certain permissions), which may then be sent to a collaboration server to establish one or more permitted sub-sessions of the online collaborative computing session with the client device as indicated by the received sub-session tokens.
    Type: Grant
    Filed: July 21, 2009
    Date of Patent: November 5, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Sihai Xiao, Zheng Yuan, David Knight
  • Interactive data forecasting features for a graphical user interface
    Patent number: 8566740
    Abstract: A computer system and related display techniques are presented here. The system generates and provides a graphical user interface (GUI) control element to enable user adjustment of sales forecast data, and provides a hover box associated with the GUI control element, the hover box graphically indicating adjustment status information for the sales forecast data. The system also provides a forecast table panel in the GUI. In response to receiving a request corresponding to selected forecast data included in the forecast table panel, the system generates an opportunities list panel in the GUI. The opportunities list panel includes a listing of individual opportunities and related status corresponding to the selected forecast data.
    Type: Grant
    Filed: April 5, 2011
    Date of Patent: October 22, 2013
    Assignee: salesforce.com, inc.
    Inventor: David Knight
  • INDOLES
    Publication number: 20130245016
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: November 30, 2011
    Publication date: September 19, 2013
    Inventors: Steven David Knight, William Henry Miller, Kenneth Allen Newlander, Sharad Kumar Verma
  • Immunoglobulin Cleavage Fragments and Disease Indicators and Compositions for Detecting and Binding Such
    Publication number: 20130239238
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 12, 2013
    Applicant: JANSSEN BIOTECH INC.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Methods and apparatuses for managing the distribution and installation of applications during a collaboration session
    Patent number: 8516476
    Abstract: In one embodiment, the methods and apparatuses request an installation of an application; detect a user requesting the application; detect a profile associated with the user; and grant permission to install the application based on an installation permission.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: August 20, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Weidong Chen, Lei Zhu, Min Zhu, Chris Kangas, Matthew Sheppard, David Knight
  • Methods and apparatuses for monitoring attention of a user during a conference
    Patent number: 8516105
    Abstract: In one embodiment, the methods and apparatuses detect devices participating in a conference; monitor the devices for an attribute corresponding to an attention level of each of the devices; and determine whether each device is active based on the attention level.
    Type: Grant
    Filed: January 25, 2007
    Date of Patent: August 20, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Jitendra Chawla, David Knight, Edward Wong, Manish Kumar, Shawn Farshchi, Eric Montoya
  • Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
    Patent number: 8501907
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: August 6, 2013
    Assignee: Janssen Biotech, Inc.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Dairy Mineral-Fortified Liquid Dairy Products And Methods Of Making
    Publication number: 20130196031
    Abstract: Disclosed are dairy products fortified with dairy minerals and methods of making the dairy products. The fortified dairy products exhibit enhanced fresh dairy flavor notes. In one aspect, the fortified dairy product is a concentrated dairy liquid. In another aspect, the fortified dairy product is a cheese product, such as cream cheese, processed cheese, or cultured cheese.
    Type: Application
    Filed: August 9, 2012
    Publication date: August 1, 2013
    Inventors: Anthony William Criezis, Bruce Edward Campbell, Lisa Ann Dierbach, Jennifer Louise Kimmel, Timothy David Knight, Joseph Michael Schuerman
  • Dairy Products With Added Dairy Minerals And Methods Of Producing The Same
    Publication number: 20130196030
    Abstract: Disclosed are dairy products with added dairy minerals and methods of making the dairy products. The dairy products with added dairy minerals exhibit enhanced fresh dairy flavor notes. In one aspect, the dairy product with added dairy minerals is a cheese product, such as cream cheese, processed cheese, or cultured cheese.
    Type: Application
    Filed: August 9, 2012
    Publication date: August 1, 2013
    Inventors: Anthony William Criezis, Bruce Edward Campbell, Lisa Ann Dierbach, Timothy David Knight, Hui-Chen Li
  • Methods and apparatuses for selectively accessing an application
    Patent number: 8423612
    Abstract: In one embodiment, the methods and apparatuses request an application; detect a user requesting the application; detect a profile associated with the user; and grant permission to access the application based on an access parameter.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: April 16, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Weidong Chen, Lei Zhu, Min Zhu, Chris Kangas, Matthew Sheppard, David Knight
  • Methods and apparatuses for automatically initiating an application
    Patent number: 8413260
    Abstract: In one embodiment, the methods and apparatuses detect an application associated with a requester; suggest the application based on a requester parameter; select the application by the requester; and automatically initiate the application for the requester.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: April 2, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Weidong Chen, Lei Zhu, Min Zhu, Chris Kangas, Matthew Sheppard, David Knight
  • Dynamically enabling features of an application based on user status
    Patent number: 8412819
    Abstract: In one embodiment, a first application detects a user's activity. Based on the user's activity detected by the first application, a type of user status is determined from among a plurality of different types of possible user status. One or more features are determined of a feature set of a second application that correspond to the type of user status detected by the first application. The corresponding one or more features of the feature set of the second application are limited to prevent the one or more features from interrupting the user's activity. One or more other features of the feature set of the second application that do not correspond to the type of user status detected by the first application are permitted.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: April 2, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: David Knight, Jason Q. Zhang, Steffen Matt, Anand Ramanathan
  • Methods and apparatuses for dynamically suggesting an application based on a collaboration session
    Patent number: 8407289
    Abstract: In one embodiment, the methods and apparatuses detect shared content during a collaboration session; detect a content type based on the shared content; suggest an application based on the content type; and initiate the application during the collaboration session.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: March 26, 2013
    Assignee: Cisco Technology, Inc.
    Inventors: Weidong Chen, Lei Zhu, Min Zhu, Chris Kangas, Matthew Sheppard, David Knight
  • Quinoline derivatives as P13 kinase inhibitors
    Patent number: 8404837
    Abstract: Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
    Type: Grant
    Filed: May 16, 2008
    Date of Patent: March 26, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Nicholas D. Adams, Joelle Lorraine Burgess, Michael Gerard Darcy, Carla A. Donatelli, Steven David Knight, Kenneth Allen Newlander, Lance Ridgers, Martha A. Sarpong, Stanley J. Schmidt